IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Speciality Medicines IPO is a Book Building IPO listing on BSE SME exchange, with an ipo size of ₹ [●] Cr. The company is based in Ahmedabad and caters to Pharmaceutical sector. Unistone Capital is the merchant banker of Speciality Medicines IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th September 2025.
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
21.71 cr.
Sector: Pharmaceutical
SME
IPO so far:
42
Merchant Banker:
Unistone Capital
SME
IPO by BRLM so far:
23
City:
Ahmedabad
SME
IPO so far:
189
Revenue (annualised):
₹
58.27
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 20.39x
Speciality Medicines IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
| Particulars | Amount |
|---|---|
| Setting up of Research and Development (R&D) Center | 12.67 |
| Product registration in the international markets | 2.99 |
| Funding for Marketing and Promotional Activities | 2.00 |
| To Meet Working Capital Requirements | 8.00 |
| General Corporate Purpose | 0.00 |
Unistone Capital Private Limited is the book-running lead manager of the Speciality Medicines IPO. Skyline Financial Services Private Limited is the Registrar for Speciality Medicines IPO.
Speciality Medicines IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Speciality Medicines IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on marketing and distribution of finished formulations of specialty pharmaceuticals. The company is launching its SME Upcoming IPO on the BSE SME exchange, using the Book Building Issue method. Speciality Medicines IPO size is ₹ [●] with fresh issue size of ₹ 0 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Speciality Medicines IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Speciality Medicines IPO allotment status on the registrars website, Skyline Financial Services Private Limited . Speciality Medicines IPO refund dates are [●].
Speciality Medicines IPO is expected to be listed on [●].
The upper price band for the Speciality Medicines IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Speciality Medicines IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Speciality Medicines IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Speciality Medicines IPO is finalised.
The merchant banker for Speciality Medicines IPO is Unistone Capital Private Limited . Unistone Capital Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Speciality Medicines IPO RHP for further details.
The registrar for Speciality Medicines IPO is Skyline Financial Services Private Limited . Investors can go to Skyline Financial Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Speciality Medicines IPO through their official website or helpline.
Speciality Medicines IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Get
Ready Image
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 21.71 Cr.
Sector: Pharmaceutical
SME
IPO so far:
42
Merchant Banker:
Unistone Capital
SME
IPO by BRLM so far:
23
City:
Ahmedabad
SME
IPO so far:
189
Revenue (annualised):
₹ 58.27 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 20.39x
Speciality Medicines IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Speciality Medicines Financial Review Page
Merchant Banker(s) of Speciality Medicines IPO: Unistone Capital Private Limited
Speciality Medicines IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Speciality Medicines IPO listed at a listing price of against the offer price of .
The current market price of Speciality Medicines is .
Why Us?
